Athanor Capital, LP Acadia Pharmaceuticals Inc Transaction History

Athanor Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $458,716 - $1.01 Million	-18,334 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $372,725 - $515,766	9,082 Added 98.16%	18,334 $980,000
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $380,261 - $595,137	-10,441 Reduced 53.02%	9,252 $382,000
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $773,147 - $1.04 Million	19,693 New	19,693 $955,000
Q1 2020 May 14, 2020	SELL	$31.65 - $46.87 $313,335 - $464,013	-9,900 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $358,479 - $508,860	9,900 New	9,900 $424,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.